Mounjaro
The only dual GIP + GLP-1 receptor agonist available in Thailand. Activates two incretin pathways simultaneously for superior appetite suppression and metabolic improvement.
- Up to 22.5% body weight reduction (SURMOUNT-1)
- Dual GIP & GLP-1 receptor activation
- Improves insulin sensitivity and blood sugar
- Once-weekly subcutaneous injection
- Structured 4-step titration: 2.5 → 5 → 7.5 → 10 mg
- Verified authentic from Zuellig Pharma
| Dose | Phase | Price |
|---|---|---|
| 2.5 mg | Starting — wk 1–4 | 11,600 |
| 5.0 mg | Step-up — wk 5–8 | 13,999 |
| 7.5 mg | Maintenance — wk 9–12 | 18,499 |
| 10.0 mg | Higher maint. — wk 13+ | 20,999 |